We are live on ! Find out more
AI

Advent International Portfolio holdings

AUM $4.24B
1-Year Est. Return 4.24%
This Fund
S&P 500
This Quarter Est. Return
-30.51%
1 Year Est. Return
+4.24%
3 Year Est. Return
+15.25%
5 Year Est. Return
-41.72%
10 Year Est. Return
+104.97%
AUM
$14.3M
AUM Growth
-$205M
Cap. Flow
-$198M
Cap. Flow %
-1,381.87%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
FIVE icon
Five Below
FIVE
+$196M
2
AEGR
Aegerion Pharmaceuticals
AEGR
+$1.86M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AEGR
1
DELISTED
Aegerion Pharmaceuticals
AEGR
$14.3M 100%
447,001
-50,000
-10% -$1.86M
FIVE icon
2
Five Below
FIVE
$11.3B
– –
-4,622,261
Closed -$196M

Similar funds

MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
SLI
Sumitomo Life Insurance Tokyo, Japan $4.25B AUM 23.69% 1-Year Est. Return
CIC
Chilton Investment Company Stamford, Connecticut $4.26B AUM 1.32% 1-Year Est. Return
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Advent International's Q2 2014 Portfolio in Review

As of Q2 2014, Advent International held 2 positions worth $14.3M, down 93% from $219M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Advent International withdrew a net $198M in Q2 2014, closing 1 position and reducing 1 holding. Its most notable exit was Five Below, an estimated $196M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary.

  • Advent International's biggest Q2 2014 reduction was Aegerion Pharmaceuticals, cutting an estimated $1.86M.
  • Advent International fully exited Five Below in Q2 2014, selling an estimated $196M.
  • Advent International's ten largest holdings make up 100% of its $14.3M portfolio in Q2 2014.
  • Advent International opened 0 new positions and closed 1 in Q2 2014.
  • Advent International's portfolio value fell 93% quarter-over-quarter to $14.3M.

Based on Advent International's 13F filing for Q2 2014, filed 11 Aug 2014.